1. Home
  2. MRIN vs GRI Comparison

MRIN vs GRI Comparison

Compare MRIN & GRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRIN
  • GRI
  • Stock Information
  • Founded
  • MRIN 2006
  • GRI 2018
  • Country
  • MRIN United States
  • GRI United States
  • Employees
  • MRIN N/A
  • GRI N/A
  • Industry
  • MRIN EDP Services
  • GRI Biotechnology: Pharmaceutical Preparations
  • Sector
  • MRIN Technology
  • GRI Health Care
  • Exchange
  • MRIN Nasdaq
  • GRI Nasdaq
  • Market Cap
  • MRIN 6.7M
  • GRI 6.1M
  • IPO Year
  • MRIN 2013
  • GRI N/A
  • Fundamental
  • Price
  • MRIN $2.11
  • GRI $0.67
  • Analyst Decision
  • MRIN
  • GRI Strong Buy
  • Analyst Count
  • MRIN 0
  • GRI 2
  • Target Price
  • MRIN N/A
  • GRI $11.50
  • AVG Volume (30 Days)
  • MRIN 30.1K
  • GRI 180.3K
  • Earning Date
  • MRIN 02-20-2025
  • GRI 11-14-2024
  • Dividend Yield
  • MRIN N/A
  • GRI N/A
  • EPS Growth
  • MRIN N/A
  • GRI N/A
  • EPS
  • MRIN N/A
  • GRI N/A
  • Revenue
  • MRIN $16,707,999.00
  • GRI N/A
  • Revenue This Year
  • MRIN N/A
  • GRI N/A
  • Revenue Next Year
  • MRIN N/A
  • GRI N/A
  • P/E Ratio
  • MRIN N/A
  • GRI N/A
  • Revenue Growth
  • MRIN N/A
  • GRI N/A
  • 52 Week Low
  • MRIN $1.44
  • GRI $0.30
  • 52 Week High
  • MRIN $5.46
  • GRI $65.00
  • Technical
  • Relative Strength Index (RSI)
  • MRIN 49.46
  • GRI 40.21
  • Support Level
  • MRIN $2.02
  • GRI $0.68
  • Resistance Level
  • MRIN $2.16
  • GRI $0.74
  • Average True Range (ATR)
  • MRIN 0.12
  • GRI 0.06
  • MACD
  • MRIN -0.01
  • GRI -0.01
  • Stochastic Oscillator
  • MRIN 23.68
  • GRI 2.36

About MRIN Marin Software Incorporated

Marin Software Inc provides a cloud-based digital advertising management solution for search, display, social, and mobile advertising channels to improve financial performance, realize efficiencies and time savings, and improve business decisions. The company's enterprise marketing software platform is offered as an integrated software-as-a-service (SaaS) solution for advertisers and agencies. Its software solution is designed to help its customers measure the effectiveness of their advertising campaigns through its reporting and analytics capabilities; and manage and execute campaigns through its user interface and underlying technology that streamlines and automates functions. All the business activity of the firm is functioned through the geographical regions of The United States.

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist, for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

Share on Social Networks: